The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Portrait of Tommy Cedervall; Photo: Kennet Ruona

Tommy Cedervall

Associate Professor, Coordinator Nanosafety

Portrait of Tommy Cedervall; Photo: Kennet Ruona

Polystyrene nanoparticles affecting blood coagulation.

Author

  • Cecilia Oslakovic
  • Tommy Cedervall
  • Sara Linse
  • Björn Dahlbäck

Summary, in English

Association of nanoparticles with blood coagulation proteins may influence the natural balance between pro-and anticoagulant pathways. We investigated whether polystyrene nanoparticles, when added to human plasma, affected the generation of thrombin in plasma. Amine-modified nanoparticles were found to decrease the thrombin formation due to binding of factor VII and IX to the nanoparticles, which resulted in depletion of the respective protein in solution. In contrast, carboxyl-modified nanoparticles were able to act as a surface for activation of the intrinsic pathway of blood coagulation in plasma. These results highlight the influence of nanoparticles on a biologically important pathway.

Department/s

  • Clinical Chemistry, Malmö
  • Biochemistry and Structural Biology
  • MultiPark: Multidisciplinary research focused on Parkinson´s disease
  • NanoLund: Center for Nanoscience

Publishing year

2012

Language

English

Pages

981-986

Publication/Series

Nanomedicine: Nanotechnology, Biology and Medicine

Volume

8

Issue

6

Document type

Journal article

Publisher

Elsevier

Topic

  • Medicinal Chemistry

Status

Published

Research group

  • Clinical Chemistry, Malmö

ISBN/ISSN/Other

  • ISSN: 1549-9642